Insider · CIK 0001253497
John Glenn
Files at IRMD (IRADIMED CORP). First filing Dec 2, 2024, latest Dec 12, 2025.
In brief
John Glenn files SEC Form 4 as CFO at IRMD (IRADIMED CORP). Since Dec 2, 2024, John Glenn has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.5M, the latest filed on Dec 12, 2025.
A track record needs three past buys with six months of prices behind them; John Glenn has 0, so none is measured yet.
The newest scored trade: sold $1.5M of IRMD on Dec 11, 2025, filed Dec 12, 2025, scored 67 (notable). In the last 12 months: 0 buys worth $0 and 2 sells worth $2.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IRMD: IRADIMED CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 67Notable | IRADIMED CORP | $1.5M 15,000 shares | -67% | +102% from low0% from high | |
| 81Strong | IRADIMED CORP | $900k 10,651 shares | -81% | +78% from low-1% from high | |
| 43Moderate | IRMDsell IRADIMED CORP | $135k 2,500 shares | -36% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 11, 2025 | IRMD IRADIMED CORP | 15,000 0.12% of outstanding | $1.5M | Dec 11, 2025 | $900k |
| Nov 10, 2025 | IRMD IRADIMED CORP | 10,651 0.08% of outstanding | $900k | Nov 10, 2025 | none |
| Jan 6, 2025 | IRMD IRADIMED CORP | 2,500 0.02% of outstanding | $135k | Dec 2, 2024 | none |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2026 | IRMD IRADIMED CORP | MOption exercise Common Stock | +5,796 | - | - | 14,256 | Jun 23, 2026 |
| Jun 20, 2026 | IRMD IRADIMED CORP | FTax withholding Common Stock | -2,319 | $92.20 | $214k | 11,937 | Jun 23, 2026 |
| Jun 20, 2026 | IRMD IRADIMED CORP | MOption exercise Restricted Stock Unitsderivative | -5,796 | $0.00 | $0 | 0 | Jun 23, 2026 |
| Mar 3, 2026 | IRMD IRADIMED CORP | AGrant or award Restricted Stock Unitsderivative | +8,907 | $0.00 | $0 | 8,907 | Mar 5, 2026 |
| Dec 11, 2025 | IRMD IRADIMED CORP | SOpen-market sale Common Stock | -14,468 | $97.26 | $1.4M | 7,894 | Dec 12, 2025 |
| Dec 11, 2025 | IRMD IRADIMED CORP | SOpen-market sale Common Stock | -532 | $98.09 | $52k | 7,362 | Dec 12, 2025 |
| Dec 11, 2025 | IRMD IRADIMED CORP | MOption exercise Common Stock | +1,812 | - | - | 9,174 | Dec 12, 2025 |
| Dec 11, 2025 | IRMD IRADIMED CORP | FTax withholding Common Stock | -714 | $97.38 | $70k | 8,460 | Dec 12, 2025 |
| Dec 11, 2025 | IRMD IRADIMED CORP | MOption exercise Restricted Stock Unitsderivative | -1,812 | $0.00 | $0 | 3,624 | Dec 12, 2025 |
| Dec 7, 2025 | IRMD IRADIMED CORP | MOption exercise Common Stock | +10,504 | - | - | 13,004 | Dec 10, 2025 |
| Dec 7, 2025 | IRMD IRADIMED CORP | FTax withholding Common Stock | -3,383 | $94.57 | $320k | 9,621 | Dec 10, 2025 |
| Dec 7, 2025 | IRMD IRADIMED CORP | MOption exercise Common Stock | +21,008 | - | - | 30,629 | Dec 10, 2025 |
| Dec 7, 2025 | IRMD IRADIMED CORP | FTax withholding Common Stock | -8,267 | $94.57 | $782k | 22,362 | Dec 10, 2025 |
| Dec 7, 2025 | IRMD IRADIMED CORP | MOption exercise Restricted Stock Unitsderivative | -10,504 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 7, 2025 | IRMD IRADIMED CORP | MOption exercise Performance-based Restricted Stock Unitsderivative | -21,008 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Nov 10, 2025 | IRMD IRADIMED CORP | SOpen-market sale Common Stock | -10,651 | $84.51 | $900k | 2,500 | Nov 12, 2025 |
| Jun 20, 2025 | IRMD IRADIMED CORP | MOption exercise Common Stock | +5,796 | - | - | 14,563 | Jun 23, 2025 |
| Jun 20, 2025 | IRMD IRADIMED CORP | FTax withholding Common Stock | -1,412 | $58.24 | $82k | 13,151 | Jun 23, 2025 |
| Jun 20, 2025 | IRMD IRADIMED CORP | MOption exercise Restricted Stock Unitsderivative | -5,796 | $0.00 | $0 | 5,796 | Jun 23, 2025 |
| Jun 20, 2024 | IRMD IRADIMED CORP | MOption exercise Restricted Stock Unitsderivative | -5,796 | $0.00 | $0 | 11,592 | Apr 7, 2025 |
| Jun 20, 2024 | IRMD IRADIMED CORP | MOption exercise Common Stock | +5,796 | - | - | 10,179 | Apr 4, 2025 |
| Jun 20, 2024 | IRMD IRADIMED CORP | FTax withholding Common Stock | -1,412 | $42.53 | $60k | 8,767 | Apr 4, 2025 |
| Jun 20, 2024 | IRMD IRADIMED CORP | MOption exercise Restricted Stock Unitsderivative | +5,796 | $0.00 | $0 | 11,592 | Apr 4, 2025 |
| Dec 11, 2024 | IRMD IRADIMED CORP | AGrant or award Restricted Stock Unitsderivative | +5,436 | $0.00 | $0 | 40,508 | Dec 13, 2024 |
| Dec 11, 2024 | IRMD IRADIMED CORP | AGrant or award Performance-based Restricted Stock Unitsderivative | +5,435 | $0.00 | $0 | 23,119 | Dec 13, 2024 |
| Dec 2, 2024 | IRMD IRADIMED CORP | SOpen-market sale Common Stock | -2,500 | $54.18 | $135k | 4,383 | Dec 2, 2024 |
Questions about John Glenn
Answered from the filings on this page, as of the latest one.
Is John Glenn buying or selling?
In the last 12 months John Glenn reported 0 open-market buys worth $0 and 2 open-market sells worth $2.4M on SEC Form 4; the latest was sold $1.5M of IRMD on Dec 11, 2025. Grants, option exercises and tax withholding are not counted.
How did John Glenn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Glenn has 0.
Where does John Glenn file Form 4?
John Glenn has filed Form 4 at IRMD (IRADIMED CORP) as CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.